SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound.
SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound. Its mission is to develop genetic medicines that treat the root cause of human disease.SonoThera is expanding the possibilities of disease treatment with ultrasound-guided nonviral gene therapy for diseases with suboptimal or non-existent treatments. It aims to improve the lives and health of millions of people.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 5, 2022 | Series A | $60.75M | 11 | ARCH Venture Partners | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
ARCH Venture Partners | Yes | Series A |
Alexandria Venture Investments | — | Series A |
Eli Lilly & Company Foundation | — | Series A |
Foothill Ventures | — | Series A |
Formic Ventures | — | Series A |
Illumina Ventures | — | Series A |
Johnson & Johnson Innovation – JJDC | — | Series A |
Lifespan Investments | — | Series A |
Medical Excellence Capital | — | Series A |
Vertex Ventures HC | — | Series A |